Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Two are better than one

Dear Sir or Madam,

When the kidney loses its function, a hemodialysis is unavoidable. Thereby, a blood vessel in the arm needs to be enlarged, so that enough blood can move. Until now, a surgical intervention was necessary where an arteriovenous fistula, a connection between artery and vein, is created. In the future, this surgery can be replaced by a minimally invasive endovascular procedure where the dialysis fistula is created by using two catheters. Read more in our current interview.

Have fun reading!

Nicole Kaufmann
Editorial team MEDICA-tradefair.com


MEDICA Trade Fair with Conferences and Forums
Monday to Thursday
14 to 17 November 2016
Düsseldorf, Germany

Table of Contents

Interview
Topic of the Month
Newsletter Service
RSS Service
Newsletter Archive

Hybrid Operating Room: The OR of the Future Today?

Topic of the Month

Bild: Hybrid OR; Copyright: Philips GmbH
Patients take center stage during surgery. Their treatment should be as gentle and effective as possible, which is why there is a trend towards minimally invasive surgery (MIS). But minimal procedures require better supporting technologies. The hybrid operating room combines surgery and imaging systems and increasingly replaces conventional open surgery approaches with MIS.
Read more in our Topic of the Month:
Intraoperative imaging
Hybrid Operating Room: The OR of the Future Today?
To top

Research & Technology

Heart valve replacement for people with rheumatic heart disease

A novel heart valve replacement method is revealed today that offers hope for the thousands of patients with rheumatic heart disease who need the procedure each year. The research was being presented at the SA Heart Congress 2016.
read more
To top

Research & Technology

Hungry cells on the move

Researchers discover a signalling pathway that enables cells to reach their destinations through repulsion.
read more
To top

Hemodialysis: Creating the AV fistula using catheters

Interview

Image: Open surgery at the forearm of a patient; Copyright: panthermedia.net/Chanawit Sitthisombat
For many patients, the start of hemodialysis marks the lifelong dependency on needing their blood purified. But before they can actually begin treatments, a blood vessel in the patient’s arm needs to be enlarged to where it can move enough blood and withstand being connected to the dialysis machine several times per week. To do this, an arteriovenous (AV) fistula, a connection between artery and vein, is surgically created.
Read more in the interview:
Hemodialysis: Creating the AV fistula using catheters
All interviews at MEDICA-tradefair.com
To top

Public Health & Associations

Voices of patients and oncologists must be heard, study says

Specifically training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in "JAMA Oncology".
read more
To top

Trade Fair News

Mobile Health bei Diabetes: Selbstmanagement vereinfachen

Diabetes is a chronic disease affecting currently more than 415 million people worldwide with a constant increase in numbers.
read more
To top

Company News

Cell-free DNA isolation for Liquid Biopsy assays

MACHEREY-NAGEL GmbH & Co. KG

MACHEREY-NAGEL is happy to announce the launch of a new product line for the isolation of cell-free DNA from human blood plasma for Liquid Biopsy assays. The new product line comprises products for...
read more
To top

Company News

Multiple Award-Winning Designs

PDR Ltd.

PDR’s customer-focused approach emphasises control and robust, reliable solutions throughout. From designing wearables to creating mind-blowing prosthetics, PDR International Centre for Design and...
read more
To top

Company News

World Innovation and Hope: First therapeutic molecule candidate against Zika viruses

Genekam Biotechnology AG

Duisburg, 07.09.16: Genekam Biotechnology AG, which developed the first test for Zikavrius detection in Januar 2016, has developed as one of first company in the world the therapeutic molecule...
read more
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top

beta-web GmbH - Partner of Messe Düsseldorf

Advertising Opportunities

As an official partner of Messe Düsseldorf, beta-web markets exclusive forms of advertisements to exhibitors of the MEDICA.

You want to be part of the newsletter and reach over 30.000 interested readers with your advertising message? Then contact us at medica@beta-web.de or call us: 0049 – 228 9193735.

For more information on our available forms of advertisements, please see our Media Kit.
Website of beta-web GmbH
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.